Sinkopa kao dominantan simptom plućne embolije – prikaz slučaja

  • Marko B Baralic Klinicki centar Srbije, Klinika za nefrologiju
  • dr Klinika za pulmologiju, Klinički centar Srbije, Beograd, Srbija
  • dr Klinika za pulmologiju, Klinički centar Srbije, Beograd, Srbija
  • dr Klinika za pulmologiju, Klinički centar Srbije, Beograd, Srbija
  • dr Klinika za grudnu hirurgiju, Klinički centar Srbije, Beograd, Srbija
  • dr Klinika za internu medicinu, Kliničko bolnički centar Zemun, Beograd, Srbija
  • dr Klinika za ortopediju i traumatologiju, Klinički centar Srbije, Beograd, Srbija
  • dr Institu za patologiju Medicinski fakultet, Univerzitet u Beogradu

Sažetak


Abstrakt

Plućna embolija (PE) i duboka venska tromboza (DVT) mogu predstavljati povezan klinički sindrom koji se manifestuje kao rezultat jednog entiteta, venskog trombo-embolizma (VTE).

 Kod većine bolesnika se plućna embolija manifestuje specifičnim trijasom simptoma u vidu dispneje, pleurodinijom i tahikardijom, dok se sinkopa retko javlja, sa incidencijom 6% kod svih bolesnika. Obzirom da se kod naše bolesnice kao dominatan simptom javila sinkopa sa blagom dispnejom teško se posumnjalo na PE, zbog čega se pristupilo dodatnoj dijagnostici u vidu doppler ultrasonografije donjih ekstremiteta i multislajsnoj angiografije plućne arterije čime je otkrivena bolest i potvrđena dijagnoza.

Sinkopa i ako čest klinički simptom se najčešće dovodi u vezi sa neurološkim ili kardiološkim događajima, ali je i dalje raskrsnica različitih internističkih bolesti jer se može prezentovati i u plućnim oboljenjima.     

Ključne reči: sinkopa, embolija, tromboza

Biografija autora

Marko B Baralic, Klinicki centar Srbije, Klinika za nefrologiju
Dr med. specijalista interne medicine

Reference

1. Effectiveness of a diagnostic algorithm combining clinical probability, D-dimer testing, and computed tomography in patients with suspected pulmonary embolism in emergency department. Galipienzo J, Garcia de Tena J, Flores J, Alvarez C, Garcia-Avello A, Arribas I.Rom J Intern Med. 2012 Jul-Sep;50(3):195-202.
2. A Silent Fatal Presentation of Pulmonary Embolism: Reflection and Discussion.
Zhang Q, Abideen ZU, Shan KS, Yoon T, Farooq M.Cureus. 2020 Jun 24;12(6):e8813. doi:10.7759/cureus.8813.
3. Trends and risk factors of mortality analysis in patients with inflammatory bowel disease: a Taiwanese nationwide population-based study. Lin WC, Weng MT, Tung CC, Chang YT, Leong YL, Wang YT, Wang HY, Wong JM, Wei SC.J Transl Med. 2019 Dec 12;17(1):414. doi: 10.1186/s12967-019-02164-3.

4. Is stand-alone D-dimer testing safe to rule out acute pulmonary embolism? van Es N, van der Hulle T, Büller HR, Klok FA, Huisman MV, Galipienzo J, Di Nisio M.J Thromb Haemost. 2017 Feb;15(2):323-328. doi: 10.1111/jth.13574. Epub 2016 Dec 24.PMID:27873439


5. Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, Goldsmith K, Coghlan JG, Pepke-Zaba J. Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur Respir J 2009;33(2):332–338.
6. Yan Z, Ip IK, Raja AS, et al. Yield of CT pulmonary angiography in the emergency department when providers override evidence-based clinical decision support. Radiology. 2017;282:717-25
7. van Es N, van der Hulle T, van Es J, et al. Wells rule and D-dimer testing to rule out pulmonary embolism: a systematic review and individualpatient data meta-analysis. Ann Intern Med 2016; 165:253-61.
8. Mos ICM, Douma RA, Erkens PMG, Kruip MJHA, Hovens MM, van Houten AA, Hofstee HMA, Kooiman J, Klok FA, Büller HR, Kamphuisen PW, Huisman M V. Diagnostic outcome management study in patients with clinically suspected recurrent acute pulmonary embolism with a structured algorithm. Thromb Res Elsevier Ltd; 2014; 133: 1039–44.
9. Rali PM, Criner GJ. Submassive pulmonary embolism. Am J Respir Crit Care Med 2018. https://doi.org/10.1164/rccm.201711-2302CI.
10. Deitelzweig SB, Lin J, Johnson BH, et al. Venous thromboembolism in the US: does race matter? J Thromb Thrombolysis 2011. https://doi.org/10.1007/ s11239-010-0503-3.
11. Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med 2017. https://doi.org/10.1056/NEJMra1700365.
12. Kroep S, Chuang L-H, Cohen A, et al. The impact of co-morbidity on the disease burden of VTE. J Thromb Thrombolysis 2018. https://doi.org/10.1007/s11239- 018-1732-0.
Objavljeno
2020/12/22
Rubrika
Prikaz bolesnika